ClinicalTrials.govpublic full text
First-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal Cancer
efficacy, self, safety issues, colo-rectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899346
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.